Making Science Group, S.A. (BME:MAKS)
Spain · Delayed Price · Currency is EUR 6.80
0.00 (0.00%)
Jul 17, 2026, 5:24 PM CET
Making Science Group Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 25.01 | -1.44 | -4.12 | -0.51 | -2.54 |
Depreciation & Amortization | 7.55 | 6.52 | 5.56 | 3.95 | 3.82 |
Stock-Based Compensation | 0.47 | 0.58 | 0.48 | 0.39 | - |
Other Adjustments | -0.99 | 6.19 | 6.2 | 4.72 | 1.09 |
Change in Receivables | -0.58 | -19.45 | -2.54 | -15.62 | -13.1 |
Changes in Inventories | 11.8 | 0.25 | -0.14 | -1.36 | -1.9 |
Changes in Accounts Payable | 0.6 | 14.02 | -0.62 | 19.55 | 13.67 |
Changes in Accrued Expenses | 23.34 | -0.39 | 0.33 | 3.24 | 8.42 |
Changes in Income Taxes Payable | -0.46 | -1.12 | -1.29 | -0.4 | -0.13 |
Changes in Other Operating Activities | -18.46 | -4.85 | -4.3 | -2.07 | -2.12 |
Operating Cash Flow | 40.25 | 0.3 | -0.42 | 11.9 | 7.21 |
Operating Cash Flow Growth | 13462.61% | - | - | 64.92% | 107.50% |
Capital Expenditures | -0.17 | -0.28 | -1.07 | -1.34 | -0.67 |
Purchases of Intangible Assets | -6.8 | -5.58 | -4.84 | -3.32 | -28.73 |
Purchases of Investments | -3.11 | -2.22 | -0.26 | -0.13 | - |
Payments for Business Acquisitions | - | - | - | 1.45 | - |
Other Investing Activities | -2.42 | - | - | - | - |
Investing Cash Flow | -12.5 | -8.08 | -6.17 | -3.34 | -29.4 |
Long-Term Debt Issued | -14.1 | -4.33 | 7.05 | -4.2 | 60.42 |
Long-Term Debt Repaid | -3.53 | -4.37 | -8.44 | -7.79 | - |
Net Long-Term Debt Issued (Repaid) | -17.63 | -8.71 | -1.39 | -11.99 | 60.42 |
Issuance of Common Stock | 1 | 16.73 | -0.25 | 8.9 | 10.56 |
Repurchase of Common Stock | - | - | -3.88 | -3.21 | - |
Net Common Stock Issued (Repurchased) | 1 | 16.73 | -4.12 | 5.69 | 10.56 |
Other Financing Activities | - | - | - | - | 0.03 |
Financing Cash Flow | -16.63 | 8.03 | -5.51 | -6.3 | 40.5 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.47 | - | 0.29 | -1.13 | -0.3 |
Net Cash Flow | 9.88 | 0.27 | -11.81 | 1.13 | 18.31 |
Free Cash Flow | 40.07 | 0.02 | -1.49 | 10.56 | 6.54 |
Free Cash Flow Growth | 189983.96% | - | - | 61.47% | 99.94% |
FCF Margin | 11.01% | 0.01% | -0.63% | 5.02% | 5.92% |
Free Cash Flow Per Share | 4.44 | 0.00 | -0.18 | 1.30 | 0.84 |
Levered Free Cash Flow | 5.6 | 3.73 | -7.01 | 8.69 | 78.02 |
Unlevered Free Cash Flow | 23.24 | 31.15 | -0.65 | 19.39 | 19.22 |